Prime Medicine Beats Beam Therapeutics In Patent Dispute - But Both Are Investable (PRME)
· seekingalpha.com
Prime Medicine, Inc. wins arbitration vs. Beam Therapeutics Inc., advancing PM647 for AATD. Read more on PRME and BEAM stocks here.
If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and ...